Dr. Dean M. Kirkel, MD

Dr. Kirkel practices at Wellstar Cobb Medical Center in Austell, Georgia, part of Wellstar Health System.

Dr. Kirkel's NPI, 1740242932, was assigned on April 4, 2006. Dr. Kirkel graduated from University of the Witwatersrand in 1999. Dr. Kirkel's Georgia license number on file is 070840.

Dr. Kirkel's primary practice is Wellstar Cobb Medical Center, at 3950 Austell Rd, Austell, GA 30106 in Cobb County. The practice phone is (770) 732-4000.

Dr. Kirkel's primary practice is Wellstar Cobb Medical Center in Austell, Georgia, part of Wellstar Health System. Dr. Kirkel is also affiliated with Wellstar Kennestone Regional Medical Center. The medical group on file is Wellstar Medical Group. Dmand AI also links Dr. Kirkel to 4 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kirkel practices, 9 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kirkel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kirkel is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Kirkel's licenses on file in 4 states: Georgia, Florida, Virginia and District of Columbia.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances and immune deficiency disease among the conditions Dr. Kirkel treats.

CMS data shows 1,555 Medicare services from Dr. Kirkel across 9 procedure codes in 2024, for 534 Medicare patients. Medicare paid $89,653 for them.

CMS counts 534 Medicare patients who saw Dr. Kirkel in 2024. The largest group is 75 to 84, with 223 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kirkel's median patient age at 74, with 55% women.

In 2024, Dr. Kirkel wrote 2,380 Medicare Part D claims for 432 patients. 81% of them were for generic drugs. CMS names the drug for 1,973 of them, across 58 drugs with 11 or more claims each, at $2,440,098 in total drug cost. In 2023, CMS named 1,677 claims across 46 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Kirkel for performance year 2024, reported through an alternative payment model (APM). Dr. Kirkel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kirkel as offering telehealth.

Dmand AI links 4 papers to Dr. Kirkel, published from 2014 to 2021. Dr. Kirkel's most frequent co-authors are Esma A. Akin, MD, Folasade A. Arinze, MD and Catherine A. Bishop, DO.

Dmand AI links Dr. Kirkel to 1 clinical trial. Conditions studied include Lymphoma, Mantle-Cell and Lymphoma, Follicular.

CMS Open Payments shows 389 general payments to Dr. Kirkel from 41 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 56% of the total. AstraZeneca Pharmaceuticals LP paid the most, $10,016.

Dr. Kirkel graduated from University of the Witwatersrand in 1999. Dr. Kirkel is a member of AOA, ASCO and ASH.

Dr. Kirkel is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.